In this study, we have investigated the effect of specific mutations in human immunodeficiency virus type 1 (HIV-1) envelope (Env) on antibody production in an effort to improve humoral immune responses to this glycoprotein by DNA vaccination. Mice were injected with plasmid expression vectors encoding HIV Env with modifications in regions that might affect this response. Elimination of conserved glycosylation sites did not substantially enhance humoral or cytotoxic-T-lymphocyte (CTL) immunity. In contrast, a modified gp140 with different COOH-terminal mutations intended to mimic a fusion intermediate and stabilize trimer formation enhanced humoral immunity without reducing the efficacy of the CTL response. This mutant, with deletions in the cleavage site, fusogenic domain, and spacing of heptad repeats 1 and 2, retained native antigenic conformational determinants as defined by binding to known monoclonal antibodies or CD4, oligomer formation, and virus neutralization in vitro. Importantly, this modified Env, gp140⌬CFI, stimulated the antibody response to native gp160 while it retained its ability to induce a CTL response, a desirable feature for an AIDS vaccine.Plasmid DNA vaccination has been a useful technology for the development and analysis of immunogens. This method of vaccination allows relevant posttranslational modifications, appropriate intracellular trafficking, and antigen presentation. Direct injection of naked DNA either intramuscularly or intradermally readily induces protective immune responses in animal models. Though DNA vaccines readily elicit cell-mediated immune responses, their ability to induce high-titer antibody responses has been limited, particularly to human immunodeficiency virus type 1 (HIV-1) envelope (Env). However, plasmid expression vectors can be readily modified to express different forms of HIV envelope proteins, enabling rapid and systematic testing of alternative vaccine immunogens.To improve the immune response to native gp160 and to expose the core protein for optimal antigen presentation and recognition, we have analyzed the immune response to modified forms of the protein. The conserved N-linked glycosylation sites previously suggested to limit the antibody response (39) were comprehensively analyzed. In addition, the important coiled-coil hairpin region involved with formation of fusion intermediates has been studied. Expression vectors with deletions in the cleavage site (C), the fusion peptide (F), and the interspace (I) between the two heptad repeats, termed ⌬CFI deletions, were prepared. In this report, the immune response to Env candidates expressed in plasmids with codons modified to improve gene expression has been analyzed. Both antibody and cytotoxic-T-lymphocyte (CTL) responses were evaluated after injection of plasmid DNA into muscle. A modified gp140 DNA has been identified that better elicits antibody responses at the same time that it retains its capacity to induce CTL responses to HIV Env. This prototype may facilitate the identification of immunogens ...